JP2024535705A5 - - Google Patents
Info
- Publication number
- JP2024535705A5 JP2024535705A5 JP2024511968A JP2024511968A JP2024535705A5 JP 2024535705 A5 JP2024535705 A5 JP 2024535705A5 JP 2024511968 A JP2024511968 A JP 2024511968A JP 2024511968 A JP2024511968 A JP 2024511968A JP 2024535705 A5 JP2024535705 A5 JP 2024535705A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- amino acid
- heavy chain
- acid sequence
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237065P | 2021-08-25 | 2021-08-25 | |
| US63/237,065 | 2021-08-25 | ||
| PCT/US2022/041400 WO2023028162A1 (en) | 2021-08-25 | 2022-08-24 | Antibodies targeting immunosuppressive b cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535705A JP2024535705A (ja) | 2024-10-02 |
| JP2024535705A5 true JP2024535705A5 (cg-RX-API-DMAC7.html) | 2025-08-29 |
Family
ID=85322045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024511968A Pending JP2024535705A (ja) | 2021-08-25 | 2022-08-24 | 免疫抑制性ｂ細胞を標的化する抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240352156A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4392063A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024535705A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118139638A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023028162A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220159989A (ko) | 2020-02-26 | 2022-12-05 | 바이오그래프 55, 인크. | C19 c38 이중특이적 항체 |
| AU2024239150A1 (en) | 2023-03-21 | 2025-10-02 | Biograph 55, Inc. | Cd19/cd38 multispecific antibodies |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007044616A2 (en) * | 2005-10-06 | 2007-04-19 | Xencor, Inc. | Optimized anti-cd30 antibodies |
| JP6594855B2 (ja) * | 2013-03-15 | 2019-10-23 | ゼンコア インコーポレイテッド | ヘテロ二量体タンパク質 |
| WO2019195535A1 (en) * | 2018-04-05 | 2019-10-10 | Novartis Ag | Trispecific binding molecules against cancers and uses thereof |
| JP7489407B2 (ja) * | 2019-05-21 | 2024-05-23 | ノバルティス アーゲー | Ｃｄ１９結合分子及びその使用 |
| WO2021173844A1 (en) * | 2020-02-26 | 2021-09-02 | Biograph 55, Inc. | C19 c38 bispecific antibodies |
| CA3199095A1 (en) * | 2020-11-06 | 2022-05-12 | Novartis Ag | Cd19 binding molecules and uses thereof |
-
2022
- 2022-08-24 JP JP2024511968A patent/JP2024535705A/ja active Pending
- 2022-08-24 US US18/685,487 patent/US20240352156A1/en active Pending
- 2022-08-24 WO PCT/US2022/041400 patent/WO2023028162A1/en not_active Ceased
- 2022-08-24 EP EP22862041.5A patent/EP4392063A4/en active Pending
- 2022-08-24 CN CN202280070738.8A patent/CN118139638A/zh active Pending